Genedrive (GDR) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Feb 2022 07:00 AM
RNS
Update on Point of Care Covid Test
15 Feb 2022 02:01 PM
RNS
Price Monitoring Extension
04 Feb 2022 07:00 AM
RNS
Notice of Results
21 Jan 2022 11:05 AM
RNS
Second Price Monitoring Extn
21 Jan 2022 11:00 AM
RNS
Price Monitoring Extension
20 Jan 2022 04:40 PM
RNS
Second Price Monitoring Extn
20 Jan 2022 04:36 PM
RNS
Price Monitoring Extension
10 Jan 2022 09:06 AM
RNS
Second Price Monitoring Extn
10 Jan 2022 09:00 AM
RNS
Price Monitoring Extension
07 Jan 2022 02:06 PM
RNS
Second Price Monitoring Extn
07 Jan 2022 02:01 PM
RNS
Price Monitoring Extension
30 Dec 2021 11:20 AM
RNS
Result of AGM
30 Dec 2021 09:05 AM
RNS
Second Price Monitoring Extn
30 Dec 2021 09:00 AM
RNS
Price Monitoring Extension
22 Dec 2021 11:06 AM
RNS
Second Price Monitoring Extn
22 Dec 2021 11:00 AM
RNS
Price Monitoring Extension
22 Dec 2021 07:00 AM
RNS
UK CTDA application for Genedrive® COV19-ID kit
20 Dec 2021 04:41 PM
RNS
Second Price Monitoring Extn
20 Dec 2021 04:36 PM
RNS
Price Monitoring Extension
20 Dec 2021 01:08 PM
RNS
Director/PDMR Shareholding
20 Dec 2021 07:00 AM
RNS
Holding(s) in Company
14 Dec 2021 02:06 PM
RNS
Second Price Monitoring Extn
14 Dec 2021 02:00 PM
RNS
Price Monitoring Extension
13 Dec 2021 04:41 PM
RNS
Second Price Monitoring Extn
13 Dec 2021 04:35 PM
RNS
Price Monitoring Extension
09 Dec 2021 11:06 AM
RNS
Second Price Monitoring Extn
09 Dec 2021 11:00 AM
RNS
Price Monitoring Extension
09 Dec 2021 09:05 AM
RNS
Second Price Monitoring Extn
09 Dec 2021 09:00 AM
RNS
Price Monitoring Extension
08 Dec 2021 04:40 PM
RNS
Second Price Monitoring Extn
08 Dec 2021 04:35 PM
RNS
Price Monitoring Extension
08 Dec 2021 02:05 PM
RNS
Second Price Monitoring Extn
08 Dec 2021 02:00 PM
RNS
Price Monitoring Extension
08 Dec 2021 12:31 PM
RNS
CE-IVD certification for Point-of-Care kit
07 Dec 2021 09:00 AM
RNS
Price Monitoring Extension
07 Dec 2021 07:00 AM
RNS
Holding(s) in Company
06 Dec 2021 04:43 PM
RNS
Additional Listing of Shares
06 Dec 2021 02:05 PM
RNS
Second Price Monitoring Extn
06 Dec 2021 02:00 PM
RNS
Price Monitoring Extension
02 Dec 2021 09:44 AM
RNS
Grant of options
02 Dec 2021 09:05 AM
RNS
Second Price Monitoring Extn
02 Dec 2021 09:00 AM
RNS
Price Monitoring Extension
30 Nov 2021 11:05 AM
RNS
Second Price Monitoring Extn
30 Nov 2021 11:00 AM
RNS
Price Monitoring Extension
29 Nov 2021 04:41 PM
RNS
Second Price Monitoring Extn
29 Nov 2021 04:36 PM
RNS
Price Monitoring Extension
29 Nov 2021 02:06 PM
RNS
Second Price Monitoring Extn
29 Nov 2021 02:01 PM
RNS
Price Monitoring Extension
29 Nov 2021 10:32 AM
RNS
Block listing Interim Review
29 Nov 2021 07:00 AM
RNS
POC kit submitted for CE-IVD certification

Genedrive plc is a medical equipment company based in Manchester, UK that develops and sells point-of-care molecular diagnostic platforms. Their products are used in healthcare settings, particularly in emergency medicine, for patient stratification and disease detection. Genedrive's goal is to improve clinical outcomes with easy-to-use tests. 

 Genedrive's major products include:
Genedrive CYP2C19 ID Kit: A rapid test that establishes metaboliser status in time-critical settings
Genedrive MT-RNR1 ID Kit: The world's first point-of-care genetic test to reduce the risk of aminoglycoside induced hearing loss

Genedrive was founded on contract research services for pharmaceutical and biotech companies, and was originally named Epistem Holdings Inc. when it was floated on the London AIM market in 2007. The company was renamed genedrive plc in 2016 to reflect its new focus on molecular diagnostics, and divested its contract research services divisions in 2018.

GDR share price launched at 129p in 2007. 

UK 100

Latest directors dealings